Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C6H12NO3S.Ca.2H2O |
| Molecular Weight | 432.567 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.[Ca++].[O-]S(=O)(=O)NC1CCCCC1.[O-]S(=O)(=O)NC2CCCCC2
InChI
InChIKey=RBTQJTVPZBDPIF-UHFFFAOYSA-L
InChI=1S/2C6H13NO3S.Ca.2H2O/c2*8-11(9,10)7-6-4-2-1-3-5-6;;;/h2*6-7H,1-5H2,(H,8,9,10);;2*1H2/q;;+2;;/p-2
| Molecular Formula | Ca |
| Molecular Weight | 40.078 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | HO |
| Molecular Weight | 17.0073 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C6H13NO3S |
| Molecular Weight | 179.237 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
400 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1379387/ |
2.2 g 3 times / day steady-state, oral dose: 2.2 g route of administration: Oral experiment type: STEADY-STATE co-administered: |
CYCLOHEXYLAMINE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1912 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1379387/ |
2.2 g 3 times / day steady-state, oral dose: 2.2 g route of administration: Oral experiment type: STEADY-STATE co-administered: |
CYCLOHEXYLAMINE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1379387/ |
2.2 g 3 times / day steady-state, oral dose: 2.2 g route of administration: Oral experiment type: STEADY-STATE co-administered: |
CYCLOHEXYLAMINE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:34:37 GMT 2025
by
admin
on
Mon Mar 31 17:34:37 GMT 2025
|
| Record UNII |
OK71859Z12
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C283
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
||
|
JECFA EVALUATION |
INS-952(II)
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
||
|
CFR |
21 CFR 189.135
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
OK71859Z12
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
5897-16-5
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
INS-952(II)
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | CYCLAMATES | ||
|
155015
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | RxNorm | ||
|
22186
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
1086447
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
m2937
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID70207706
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
Calcium cyclamate
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
SUB13172MIG
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY | |||
|
C77136
Created by
admin on Mon Mar 31 17:34:37 GMT 2025 , Edited by admin on Mon Mar 31 17:34:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |